Skip to content
Screener

Citius Oncology, Inc. CTOR Q3 2025 earnings

Reported August 12, 2025 · Before market open

EPS-$0.08Beat by $0.07
EPS estimate-$0.15

Next report

Date not yet announced

Financials

Q3 2025

Income statement

See full
Operating income-$4.9M-6.8%
Net income-$5.4M-12.5%
EPS (diluted)-$0.08-14.3%

Balance sheet

See full
Cash & equivalents$112.0-57.1%
Total equity$32.4M+90.2%
Total assets$91.7M+86.4%

Cash flow

See full
Operating cash flow-$1.4M-4,447%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$190.33M—

Returns & leverage

See full
Return on equity-107.5%—
Current ratio0.3×+0.3×

FAQ

When did Citius Oncology, Inc. report Q3 2025 earnings?
Citius Oncology, Inc. (CTOR) reported Q3 2025 earnings on August 12, 2025 before market open.
What were Citius Oncology, Inc.'s Q3 2025 revenue and EPS?
Citius Oncology, Inc. reported eps of $-0.08 for Q3 2025.
Did Citius Oncology, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.15 by $0.07.
How did Citius Oncology, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 11.5% from $-0.07.
Where can I find Citius Oncology, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-075014) and the 10-Q periodic report (0001213900-25-074992) directly on SEC EDGAR. The filing index links above go to sec.gov.